Physician profile
Wayne D Hey
NPI 1114114279
$11,484.25
in general payments reported to CMS, 2019-2025
47 companies · $2,671 in 2025
The $2,671 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $706 · 2020: $781 · 2021: $1,132 · 2022: $1,667 · 2023: $1,875 · 2024: $2,652 · 2025: $2,671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,998 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,998.26 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $3,103.37 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Astellas Pharma US INC | $1,377.96 | 2019-2025 | Xtandi, Veozah, Myrbetriq |
| Endo Pharmaceuticals INC. | $799.33 | 2019-2024 | Xiaflex, Aveed, Edex |
| Sumitomo Pharma America, INC. | $598.53 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $509.30 | 2019-2025 | |
| Endo USA, INC. | $371.94 | 2024-2025 | Xiaflex, Aveed |
| Procept Biorobotics Corporation | $371.88 | 2024-2025 | Aquabeam System |
| Dendreon Pharmaceuticals LLC | $362.52 | 2019-2025 | Provenge |
| Myovant Sciences INC. | $300.62 | 2021-2022 | |
| Medtronic, INC. | $283.58 | 2022-2025 | Interstim |
| Accord Healthcare, INC. | $269.35 | 2022-2025 | |
| Antares Pharma, INC. | $236.33 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Urogen Pharma, INC. | $213.25 | 2021-2025 | |
| Progenics Pharmaceuticals, INC. | $205.00 | 2023-2025 | Pylarify |
| Bayer Healthcare Pharmaceuticals INC. | $187.03 | 2021-2024 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $181.66 | 2022-2025 | Erleada |
| Urovant Sciences INC | $168.10 | 2022 | |
| Convatec INC. | $160.67 | 2023-2024 | |
| Mission Pharmacal Company | $153.80 | 2020-2025 | Uribel Tabs, Uribel |
| 180 Medical, INC. | $147.69 | 2019-2025 | Gentlecath, Gentlecath Glide |
| Johnson & Johnson Health Care Systems INC. | $140.63 | 2024 | Stelara |
| Boston Scientific Corporation | $138.48 | 2019-2025 | Bulkamid |
| Merck Sharp & Dohme LLC | $129.67 | 2020-2023 | Lynparza |
| Abbvie INC. | $122.08 | 2021-2025 | |
| Clarus Therapeutics INC. | $119.36 | 2021 | |
| Blue Earth Diagnostics | $89.27 | 2020-2025 | Posluma |
| Valencia Technologies Corporation | $87.02 | 2025 | Ecoin Device Kit |
| Tolmar, INC. | $84.96 | 2024-2025 | Eligard, Jatenzo |
| Halozyme INC | $50.38 | 2023 | |
| Civco Medical Instruments | $48.40 | 2025 | |
| Mimedx Group, INC. | $47.87 | 2024 | |
| Foundation Medicine, INC. | $45.15 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $44.95 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Acerus Pharmaceuticals Corporation | $44.57 | 2020-2021 | |
| Axonics, INC. | $38.95 | 2022-2023 | Bulkamid |
| Angiodynamics, INC. | $32.80 | 2023 | Nanoknife |
| Olympus America INC. | $32.68 | 2021 | |
| Medtronic USA, INC. | $26.83 | 2019-2020 | |
| Travere Therapeutics, INC. | $25.71 | 2020 | |
| Azurity Pharmaceuticals, INC. | $21.22 | 2025 | Azmiro |
| Teleflex LLC | $20.32 | 2023 | Urolift |
| Isoray, INC | $19.22 | 2020 | |
| Metuchen Pharmaceuticals | $14.82 | 2019 | |
| Tela Bio, INC. | $14.69 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Novartis Pharmaceuticals Corporation | $14.65 | 2025 | |
| Cook Medical LLC | $14.32 | 2023 | Resonance |
| Rochester Medical Corporation | $13.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Hey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.